Attorneys for creditors of a Massachusetts pharmacy linked to a nationwide meningitis outbreak say they have reached a preliminary settlement that would set up a victim compensation fund worth more than $100 million.
Nearly a year after a nationwide meningitis outbreak, a multi-party lawsuit is moving forward suing New England Compounding Center in Framingham with negligence.
Massachusetts officials have ordered 11 compounding pharmacies to completely or partially shut down after a series of recent unannounced state inspections.
A judge has agreed to appoint an independent trustee to oversee the bankruptcy of the compounding pharmacy linked to a nationwide meningitis outbreak.
The owners of a pharmacy linked to a fatal meningitis outbreak received more than $16 million in wages and payments as the company grew increasingly prosperous in its final months.
A drug company with the same founders as a compounding pharmacy linked to a meningitis outbreak has agreed to remain closed until at least Feb. 22.
Massachusetts has taken action against three more compounding pharmacies following unannounced inspections that were ordered in the wake of a deadly fungal meningitis outbreak linked to a Framingham pharmacy.
A federal grand jury has begun to hand down subpoenas in its investigation of the deadly meningitis outbreak linked to a Framingham pharmacy.
Massachusetts Health and Human Services Secretary JudyAnn Bigby says state overseers and the managers of a compounding pharmacy bear responsibility for a fatal, nationwide outbreak of fungal meningitis.
The state’s oversight of compounding pharmacies will be the subject of a legislative hearing.